Factory supply Doxorubicin Hcl/Hydrochloride CAS 25316-40-9 CAS NO.25316-40-9
- FOB Price: USD: 100.00-100.00 /Gram Get Latest Price
- Min.Order: 2 Gram
- Payment Terms: L/C,D/A,D/P,T/T,Other
- Available Specifications:
USP(100-500)Gram
- Product Details
Keywords
- Doxorubicin hcl
- Doxorubicin hydrochloride
- Doxorubicin powder
Quick Details
- ProName: Factory supply Doxorubicin Hcl/Hydroch...
- CasNo: 25316-40-9
- Molecular Formula: C27H30ClNO11
- Appearance: white powder
- Application: Anticancer
- DeliveryTime: in 7 days
- PackAge: 10G/bag or as your requirement
- Port: Shanghai/Beijing/Tianjin/Xiamen
- ProductionCapacity: 10 Metric Ton/Year
- Purity: 99%
- Storage: room temperature
- Transportation: Regualar transportation
- LimitNum: 2 Gram
- Related Substances: 0.1%
- Residue on Ignition: 0.5%
- Heavy Metal: 10ppm
- Valid Period: 2 years
Superiority
Why is SINOWAY:
1) Specialized in pharmaceutical and healthcare industrial for 34 years.
2) ISO 9001:2015 & SGS audited supplier .
3) Accept various payment terms : T.T 30-60 days.
4) We have warehouse in USA with quickly shipment .
5) We can do different terms of FOB ,CIF/CIP ,DDP ...
Details
1. Company Profile:
SINOWAY INDUSTRIAL CO.,LTD is a state-owned company and a professional supplier in exporting Pharmaceutical Raw and its intermediates, Cosmetic Raw Material, Healthcare Product from Chinasince 1987, about 34 years experiences to Europe, America and Southeast Asia. We have gained very good reputation from all our customers in the world.Custom manuafacturing is very strong from us.We have developed some new items together with our local universityand institute special for our oversea clients for long term business under signing secret agreement.
2. The COA of Doxorubicin Hcl
3. The use of Doxorubicin hcl
Doxorubicin is an aperiodic specific anti-tumor drug with a wide anti-tumor spectrum. It can be clinically used in breast cancer, lung cancer, lymphatic cancer, ovarian cancer and other cancers.As a second-line antitumor agent, doxorubicin can be used for treatment when the drug of choice is resistant.